Azeron Pharmaceuticals Private Limited
About Azeron Pharmaceuticals Private Limited
Data last updated:
Azeron Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 03 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC170285. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikas Ramashankar Mishra and Ajay Kumar Shukla.
Its last annual general meeting (AGM) was held on 02 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Fl No.403 S No 50/13/2 Shivraj Capital Phase – 1, Pune, Maharashtra, India – 411041.
As per the financials filed for FY 2022, the company reported a revenue of ₹26.11 Lakh, a growth of 50% compared to the previous year. For the same year it recorded a net loss of ₹15,783 (net margin -0.6%) and EBITDA of -₹15,783 (EBITDA margin -0.6%). Revenue has grown at a compounded annual rate (CAGR) of 83% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Azeron Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFl No.403 S No 50/13/2 Shivraj Capital Phase – 1, Pune, Maharashtra, India – 411041
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Azeron Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Azeron Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Azeron Pharmaceuticals Private Limited, buy the company report.
Financials of Azeron Pharmaceuticals Private Limited
FY 2022 filings availableAzeron Pharmaceuticals Private Limited reported revenue of ₹26.11 Lakh (up 50% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 83% over three years, including 50% growth in the latest year. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹26.11 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹15,783 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹15,783 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.6% | ||||
| Net Profit Margin | -0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Azeron Pharmaceuticals Private Limited, buy the company report.
Board of directors of Azeron Pharmaceuticals Private Limited
Azeron Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Ramashankar Mishra | Director | 03 May 2017 | 9 Years 6 Months | Current |
| Ajay Kumar Shukla | Director | 03 May 2017 | 9 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Azeron Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Azeron Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Azeron Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Azeron Pharmaceuticals Private Limited, buy the company report.
Recent activity
Azeron Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Ajay Kumar Shukla was appointed as Director on 03 May 2017.
Frequently asked questions
Azeron Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 03 May 2017 (9+ years old) and is registered under CIN U74999PN2017PTC170285.
Azeron Pharmaceuticals has 2 current directors:
- Vikas Ramashankar Mishra - Director
- Ajay Kumar Shukla - Director
The latest financial statements of Azeron Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 02 September 2022. Year-wise statements from FY 2018 are in the company report.
No. Azeron Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Azeron Pharmaceuticals is U74999PN2017PTC170285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Azeron Pharmaceuticals was incorporated on 03 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
Ajay Kumar Shukla was appointed as Director on 03 May 2017. Vikas Ramashankar Mishra was appointed as Director on 03 May 2017.
The registered office of Azeron Pharmaceuticals is at Fl No.403 S No 50132 Shivraj Capital Phase – 1, Pune, Maharashtra, India – 411041.
Azeron Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Azeron Pharmaceuticals is compliant as of 25 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
